基于表面修饰的纳米载体与针对肝脏受体的生物分子配体结合的输送策略
Yuhang Jiao1, Huiling Zuo1, Fengyu Wang1
1The Key Laboratory of Microcosmic Syndrome Differentiation, Yunnan University of Chinese Medicine, Kunming, Yunnan, 650500, China; Yunnan Key Laboratory of Integrated Traditional Chinese and Western Medicine for Chronic Disease in Prevention and Treatment, Yunnan University of Chinese Medicine, Kunming, Yunnan, 650500, China.
Colloids and surfaces. B, Biointerfaces
|August 20, 2025
概括
连接物修饰增强了纳米载体的向药物传递,特别是在肝脏. 本综述探讨了开发有效肝药向系统的策略和挑战.
科学领域:
- 生物医学工程
- 纳米技术
- 药理学
背景情况:
- 对纳米载体的表面修饰对于提高药物输送效率至关重要.
- 使用糖和等分子进行基修饰是关键的功能化策略.
- 通过与纳米载体上的特定受体结合,使得带能够进行向的传递.
研究的目的:
- 系统地审查针对肝脏的联体修饰纳米载体的策略.
- 分析这些修改对纳米载体性能的影响.
- 检查肝脏药物向的挑战和未来方向.
主要方法:
- 对肝脏向的多种连接物修饰策略的文献综述.
- 基于配体修饰的纳米载体性能分析.
- 审查当前的研究挑战和未来的前景.
主要成果:
- 连接物修饰提高了纳米载体向效率,用于肝脏特定的药物输送.
- 不同的配体类型和结合机制影响了纳米载体的性能.
- 成功向肝脏需要仔细考虑配体选择和结合相互作用.
结论:
- 用基修饰的纳米载体对晚期肝病治疗具有显著的前景.
- 克服当前的挑战是实现向肝脏药物的全部潜力的关键.
- 未来的研究应该集中在创新的配体设计和有针对性的输送系统上.
相关概念视频
Drug Delivery: Overview
422
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
422
Drug Biotransformation: Overview
2.9K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.9K
Drug Distribution: Tissue Binding
3.2K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
3.2K
Tissue-Drug Binding: Localization of Drugs and its Significance
163
Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
163
Routes of Drug Administration: Enteral
4.4K
Medications can be administered through the enteral route using liquids, capsules, or tablets.
Enteral administration involves drug administration via the mouth in two ways: orally or sublingually.
Unlike sublingually drugs, drugs that are taken orally pass through the gastrointestinal (GI) tract and get metabolized by the liver. Once metabolized, the drug is absorbed into the systemic circulation, reaching different body parts via the bloodstream. However, while passing through the stomach,...
Enteral administration involves drug administration via the mouth in two ways: orally or sublingually.
Unlike sublingually drugs, drugs that are taken orally pass through the gastrointestinal (GI) tract and get metabolized by the liver. Once metabolized, the drug is absorbed into the systemic circulation, reaching different body parts via the bloodstream. However, while passing through the stomach,...
4.4K
Receptor-mediated Endocytosis
105.7K
Overview
105.7K


